Journal article icon

Journal article

Changes in CD44 isoform expression during inflammatory skin disease.

Abstract:
The CD44 family of cell surface glycoproteins is widely expressed in epithelial, mesothelial and haemopoietic tissues and is thought to function primarily as adhesion molecules. The molecule has an intracellular, a transmembrane and an extracellular domain. The membrane proximal region of the extracellular domain is of variable structure depending on which of 10 variable exons are involved in coding for this region. Both in vitro stimulated T cells and cytokine stimulated keratinocytes are known to express certain isoforms. In this study we have investigated whether specific isoforms of the CD44 molecule are expressed on epithelial cells and lymphocytes in the course of two inflammatory skin diseases, namely lupus erythematosus and lichen planus. Monoclonal antibodies, specific to the epitopes of the CD44 molecule encoded by v3, v4/5, v6 and v8/9 variable exons and a pan CD44 marker, were used on 10 lupus and 8 lichen planus frozen skin samples and compared with normal skin from 9 different body sites. Results failed to show detectable levels of variant isoforms of CD44 on lymphocytes in either inflammatory skin disease, despite evidence of T cell activation. All CD44 variant isoforms were reduced on the keratinocytes in some sections of lupus and lichen planus. The results are discussed in the context of the current models for the role of CD44 in the immune response.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1046/j.1365-2230.1997.2160633.x

Authors


Journal:
Clinical and experimental dermatology More from this journal
Volume:
22
Issue:
3
Pages:
128-133
Publication date:
1997-05-01
DOI:
EISSN:
1365-2230
ISSN:
0307-6938


Language:
English
Keywords:
Pubs id:
pubs:21890
UUID:
uuid:15da219a-74bb-400a-a7c3-6359e027dcae
Local pid:
pubs:21890
Source identifiers:
21890
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP